Trial
NCT00816478
Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwell Health
Collaborators
—
Condition
Focal Segmental Glomerulosclerosis
Intervention
Galactose
Why stopped
Study closed by Institutional Review Board
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-10